CureVac’s COVID-19 vaccine (CVnCoV)

Withdrawn from rolling review

This medicine has been withdrawn from evaluation under rolling review

COVID-19 mRNA vaccine

Overview

EMA has ended the rolling review of CVnCoV, CureVac’s COVID-19 vaccine, after the company informed the Agency that it was withdrawing from the process.

The rolling review started on 12 February 2021; the company withdrew on 11 October 2021.

Key facts

• Name of medicine:
  CureVac’s COVID-19 vaccine (CVnCoV)
• International non-proprietary name (INN) or common name:
  COVID-19 mRNA vaccine
• EMA product number:
  EMEA/H/C/005845
• Developer:
  CureVac AG
• Start of rolling review:
  12/02/2021
• Withdrawal from rolling review:
  11/10/2021